Creative Medical Technology Holdings Gross Profit

The latest gross profit for CELZ is $33K as of June 2026. That compares with $-27K in the prior-year period — up 220.7% year over year. That is below the sector sector average of $750M. Investors often review this figure alongside Creative Medical Technology Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, CELZ's gross profit moved from $-27K to $33K — a 220.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Creative Medical Technology Holdings's operating scale or balance-sheet position.

Against its sector companies, CELZ currently prints $33K for gross profit, while the sector average sits near $750M. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Creative Medical Technology Holdings's growth, margins, and balance sheet.

A gross profit figure of $33K for CELZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $750M. Explore the charts below for those layers of context.

After noting CELZ's gross profit ($33K), review year-over-year change from $-27K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.